This Bill Brief outlines selected aspects of proposed changes to the Drugs, Poisons and Controlled Substances Act 1981, in relation to the medicines pharmacists may be able to prescribe without a prescription and how this will impact the health system. It provides a jurisdictional comparison on what other Australian states have done in this space...

The objective of this paper is to determine the true nature of a series of Community Pharmacy Agreements between the Federal Government and the Pharmacy Guild of Australia and whether these agreements serve the public’s access and use of medicines. The paper concludes that the Agreements can be characterised predominantly as industry policy benefiting pharmacy...

As the COVID-19 pandemic enters its fourth year, this report identifies four key lessons from the failure of States and pharmaceutical companies to comply with their human rights obligations and responsibilities to ensure fair access to COVID-19 vaccines globally.

This review report provides an overview of the context in which Community Pharmacy Agreements have developed over time and an analysis of the impacts of specific changes made by the Seventh Community Pharmacy Agreement in respect of pharmacy remuneration, wholesale supply and distribution arrangements, and new and amended programs, services and activities supported under the...

Antimicrobial resistance is one of the most serious global public health threats of the 21st Century. This paper argues that now is the time for strong and sustained action on antimicrobial resistance, as this may well be the cause of the next global pandemic.